Cargando…
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer
The third-generation aromatase inhibitors (AIs) anastrozole, exemestane and letrozole have largely replaced tamoxifen as the preferred treatment for hormone receptor – positive breast cancer in postmenopausal women. Approximately 185,000 new cases of invasive breast cancer are diagnosed yearly, and...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228389/ https://www.ncbi.nlm.nih.gov/pubmed/17892469 http://dx.doi.org/10.1111/j.1742-1241.2007.01587.x |